| 000 | 01513 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513212608.0 | ||
| 264 | 0 | _c20000922 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-200006000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaffen, E | |
| 245 | 0 | 0 |
_aOn the assessment of drug metabolism by assays of codeine and its main metabolites. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cJun 2000 |
||
| 300 |
_a258-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 |
_aCodeine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2D6 _xgenetics |
| 650 | 0 | 4 |
_aDebrisoquin _xmetabolism |
| 650 | 0 | 4 |
_aDextromethorphan _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucuronides _xurine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethylation |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorphine _xurine |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aPaintaud, G | |
| 700 | 1 | _aBerard, M | |
| 700 | 1 | _aMasuyer, C | |
| 700 | 1 | _aBechtel, Y | |
| 700 | 1 | _aBechtel, P R | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 22 _gno. 3 _gp. 258-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-200006000-00005 _zAvailable from publisher's website |
| 999 |
_c10801490 _d10801490 |
||